248 related articles for article (PubMed ID: 51680)
41. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Marti JH; Thomson DM
Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
[TBL] [Abstract][Full Text] [Related]
42. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
Herberman RB; Hollinshead AC; von Kleist S
Ann Immunol (Paris); 1973 Nov; 124(4):597-8. PubMed ID: 4134476
[No Abstract] [Full Text] [Related]
43. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
44. Expression of CALLA/CD10 on human melanoma cells.
Carrel S; Zografos L; Schreyer M; Rimoldi D
Melanoma Res; 1993 Oct; 3(5):319-23. PubMed ID: 8292887
[TBL] [Abstract][Full Text] [Related]
45. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
47. Serological reactivity in cancer patients to human and mouse fetal liver cells.
Salinas FA; Sheikh KM; Chandor SB
Cancer Res; 1978 Feb; 38(2):401-7. PubMed ID: 340028
[TBL] [Abstract][Full Text] [Related]
48. Two antigens detected on human ocular melanomas with the mouse monoclonal antibodies 2/10SN and 10/12SN.
Safi N; Kantor RR; Atkinson B; Moratz C; Wilt AR; Pancake S; Reba R; Mathieson BJ; Desgrez A
Int J Cancer; 1992 Jul; 51(5):718-26. PubMed ID: 1612780
[TBL] [Abstract][Full Text] [Related]
49. Circulating human mammary epithelial antigens in breast cancer.
Ceriani RL; Sasaki M; Sussman H; Wara WM; Blank EW
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5420-4. PubMed ID: 6957872
[TBL] [Abstract][Full Text] [Related]
50. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
51. Humoral immune response in melanoma and glioma patients: a solubilized melanoma-membrane component as a tool for detecting circulating antibodies.
Birkmayer GD
Cancer; 1981 Dec; 48(11):2399-408. PubMed ID: 7296490
[TBL] [Abstract][Full Text] [Related]
52. Skin tests with soluble melanoma antigens in patients with choroidal tumors.
Char DH; Hollinshead A; Herberman RB
Cancer; 1977 Oct; 40(4):1650-4. PubMed ID: 907975
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
Fink LM; Clarke SM
Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
[No Abstract] [Full Text] [Related]
55. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
[TBL] [Abstract][Full Text] [Related]
56. Blood-group precursors and cancer-related antigens.
Feizi T; Turberville C; Westwood JH
Lancet; 1975 Aug; 2(7931):391-3. PubMed ID: 51193
[TBL] [Abstract][Full Text] [Related]
57. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
58. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
59. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
60. Production and characterization of xenogeneic antisera to tumor-associated antigen(s).
Gupta RK; Silver HK; Morton DL
J Surg Oncol; 1980; 13(1):75-89. PubMed ID: 6153230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
